1. Home
  2. NOG vs NBTX Comparison

NOG vs NBTX Comparison

Compare NOG & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northern Oil and Gas Inc.

NOG

Northern Oil and Gas Inc.

HOLD

Current Price

$18.58

Market Cap

2.1B

Sector

Energy

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$39.95

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOG
NBTX
Founded
2006
2003
Country
United States
France
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
NOG
NBTX
Price
$18.58
$39.95
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$31.14
$36.00
AVG Volume (30 Days)
4.0M
79.6K
Earning Date
04-28-2026
03-31-2026
Dividend Yield
6.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,475,723,000.00
N/A
Revenue This Year
$14.07
$58.17
Revenue Next Year
$4.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.23
N/A
52 Week Low
$17.18
$4.93
52 Week High
$31.17
$57.14

Technical Indicators

Market Signals
Indicator
NOG
NBTX
Relative Strength Index (RSI) 41.77 56.41
Support Level N/A $38.89
Resistance Level $22.86 $41.89
Average True Range (ATR) 0.74 2.52
MACD 0.19 0.50
Stochastic Oscillator 47.88 70.20

Price Performance

Historical Comparison
NOG
NBTX

About NOG Northern Oil and Gas Inc.

Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: